Man Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-105,221
| Closed | -$551K | – | 2176 |
|
|
2024
Q1 | $551K | Buy |
105,221
+43,677
| +71% | +$229K | ﹤0.01% | 1629 |
|
|
2023
Q4 | $322K | Buy |
+61,544
| New | +$322K | ﹤0.01% | 1676 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1455 |
|
|
2022
Q4 | – | Sell |
-68,686
| Closed | -$1.82M | – | 2250 |
|
|
2022
Q3 | $1.82M | Buy |
+68,686
| New | +$1.82M | 0.01% | 1088 |
|
|
2022
Q2 | – | Sell |
-139,273
| Closed | -$6.89M | – | 793 |
|
|
2022
Q1 | $6.89M | Sell |
139,273
-7,200
| -5% | -$356K | 0.02% | 755 |
|
|
2021
Q4 | $7.46M | Buy |
146,473
+12,700
| +9% | +$647K | 0.02% | 713 |
|
|
2021
Q3 | $7.46M | Sell |
133,773
-4,100
| -3% | -$229K | 0.03% | 678 |
|
|
2021
Q2 | $5.9M | Sell |
137,873
-4,800
| -3% | -$205K | 0.02% | 810 |
|
|
2021
Q1 | $5.96M | Buy |
142,673
+40,553
| +40% | +$1.69M | 0.03% | 612 |
|
|
2020
Q4 | $4.76M | Sell |
102,120
-21,800
| -18% | -$1.02M | 0.02% | 838 |
|
|
2020
Q3 | $5.26M | Buy |
123,920
+56,833
| +85% | +$2.41M | 0.02% | 783 |
|
|
2020
Q2 | $3.22M | Sell |
67,087
-1,605
| -2% | -$77K | 0.02% | 866 |
|
|
2020
Q1 | $3.16M | Sell |
68,692
-16,566
| -19% | -$762K | 0.02% | 683 |
|
|
2019
Q4 | $5.12M | Sell |
85,258
-21,364
| -20% | -$1.28M | 0.02% | 987 |
|
|
2019
Q3 | $6.03M | Sell |
106,622
-29,613
| -22% | -$1.68M | 0.02% | 787 |
|
|
2019
Q2 | $7.59M | Buy |
136,235
+120,835
| +785% | +$6.73M | 0.03% | 758 |
|
|
2019
Q1 | $778K | Buy |
+15,400
| New | +$778K | ﹤0.01% | 1630 |
|
|
2018
Q4 | – | Sell |
-4,769
| Closed | -$331K | – | 2141 |
|
|
2018
Q3 | $331K | Buy |
+4,769
| New | +$331K | ﹤0.01% | 1913 |
|